| Turkey | Austria | Spain | |
| Whipple surgery | from $18,000 | from $45,000 | from $25,000 |
| Uterine Trachelectomy | from $5,500 | from $14,500 | from $10,000 |
| Robotic da Vinci prostatectomy | from $17,000 | from $20,000 | from $10,000 |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Proton-beam therapy | from $70,000 | from $80,000 | from $25,962 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Adenocarcinoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Adenocarcinoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Adenocarcinoma treatment journey.
Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.
She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.
Dr. Joan Albanell Mestres is a leading oncologist who specializes in breast cancer. He earned his MBBS from the University Autónoma de Barcelona in 1989. He leads the breast cancer program at HM Delfos and oversees Oncology services at Clin del Mar in Spain.
Dr. Albanell has published 120 scientific articles, with over 9,000 citations. He directs cancer research at Del Mar. He is also an active member of GEICAM, CIBERONC, AIECA, and SEOM. He regularly contributes to important oncology research.